High-value clinical tech often faces CFO resistance due to differing views on ROI timing and measurable financial impact.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

In the latest webinar of HealthLeaders' The Winning Edge series, a three-member panel will explore clinical care technology beyond artificial intelligence. In recent years, artificial intelligence has ...

For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s explore ...

A three-member panel of experts shares how to effectively use technology such as remote patient monitoring, wearables, and electronic health records. The latest webinar for HealthLeaders' The Winning ...

As the Centers for Medicare & Medicaid Services ratchets up its expectations of medical directors, data reflecting their responsibilities and the time they spend influencing nursing home care is ...

Clinical trials are critical to the future of the healthcare system. While already a well-established activity, clinical trial protocols and compliance are always evolving. This continual ...

When looking to invest in new technology, hospitals and health systems are most concerned with whether that system or technology will improve clinical performance, according to a study by Royal ...

This medical technology stock is back in a buy zone and nearing its all-time high.

CELZ-201-DDT is a proprietary allogeneic regenerative therapy designed to target the underlying pathology of DDD. Administered via ultrasound-guided injection, it offers a minimally invasive, ...